Clinical outcomes, local–regional control and the role for metastasis-directed therapies in stage III non-small cell lung cancers treated with chemoradiation and durvalumab
Michael Offin, Narek Shaverdian, Andreas Rimner, Stephanie Lobaugh, Annemarie F. Shepherd, Charles B. Simone, Daphna Y. Gelblum, Abraham J. Wu, Nancy Y. Lee, Mark G. Kris, Charles M. Rudin, Zhigang Zhang, Matthew D. Hellmann, Jamie E. Chaft, Daniel R. Gomez
Topics & Concepts
DurvalumabMedicineInternal medicineOncologyStage (stratigraphy)RegimenIncidence (geometry)CancerImmunotherapyNivolumabPaleontologyPhysicsOpticsBiologyLung Cancer Diagnosis and TreatmentLung Cancer Treatments and MutationsCancer Immunotherapy and Biomarkers